CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Drugs.com FDA MedWatch Alerts
Original article

Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial Due to the Presence of Particulate Matter

RegulatoryBrevital Sodium 500 mg/vialNegative
AI Analysis

Summary

Par Health voluntarily recalled two lots of Brevital Sodium 500 mg/vial to the hospital level due to the presence of particulate matter in the injectable drug product.

Outcome Details

Voluntary nationwide recall of two lots due to presence of particulate matter

Importance:4/10
Sentiment:
-0.70
product recallquality issueparticulate mattervoluntary recall
Related Companies

Read the original article

Published by Drugs.com FDA MedWatch Alerts on October 8, 2026 1:39 PM

Read Original